This site is intended for U.S. Healthcare professionals
Important Safety Information
Why XADAGO Now?
Limitations of Levodopa
XADAGO Clinical Efficacy
Who Can XADAGO Help?
Identifying XADAGO Patients
XADAGO Patient Profiles
How XADAGO Works
XADAGO Mechanism of Action
Dosing and Administration
Getting Patients Started
Prescription Savings Program
XADAGO Together Patient Support
HOW XADAGO WORKS
offers highly selective inhibition of monoamine oxidase B (MAO-B)
XADAGO is a highly selective inhibitor of MAO-B
The precise mechanism by which XADAGO exerts its effects in PD is unknown
There are no dietary restrictions at recommended doses of XADAGO
XADAGO HAS OVER
1000-FOLD GREATER SELECTIVITY
FOR MAO-B OVER MAO-A
NEXT: Learn about the once-daily dosing of XADAGO
In the event of formulary restrictions, we can help your patients
Find additional resources and support for patients with PD
XADAGO Full Prescribing Information. May 2017.
Onofrj M, Bonanni L, Thomas A. An expert opinion on safinamide in Parkinson’s disease.
Expert Opin Investig Drugs
. 2008;17(7):1115 1125.